DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Encinitas, CA

12 verified pulmonary disease doctors in Encinitas.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Medical Board of California

Dr. Robert Savage, MD

Pulmonary Disease

21 yrs NPPES
NPI 1881694891
320 SANTA FE DR, SUITE 308, Encinitas, CA 92024(760) 632-4269
NPPES public registry
CMS Open Payments· $17.18 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$17.18

Total received

1

Transactions

1

Paying companies

Top paying companies

AbbVie Inc.$17.18

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is on the lower end — around the 47th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Robert Savage do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Kevin Fussell, MD

Pulmonary Disease

21 yrs NPPES
NPI 1164404901
326 SANTA FE DR STE 100, Encinitas, CA 92024(760) 230-8994
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $148,319 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$148,319

Total received

240

Transactions

14

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$101,868
Regeneron Healthcare Solutions, Inc.$33,165
Genzyme Corporation$12,577
Philips North America LLC$133.45
Boehringer Ingelheim Pharmaceuticals, Inc.$116.48
GlaxoSmithKline, LLC.$116.38

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 98% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Kevin Fussell do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Scott Eisman, MD

Pulmonary Disease

20 yrs NPPES
NPI 1275511420
354 SANTA FE DR, Encinitas, CA 92024(760) 943-8806
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $38.55 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$38.55

Total received

2

Transactions

2

Paying companies

Top paying companies

Gilead Sciences, Inc.$20.11
GlaxoSmithKline, LLC.$18.44

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 52th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Scott Eisman do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Dennis Amundson, DO

Pulmonary Disease

20 yrs NPPES
NPI 1477524403
320 SANTA FE DR, SUITE 308, Encinitas, CA 92024(760) 632-4269
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. William Hooper, MD

Pulmonary Disease

20 yrs NPPES
NPI 1720052988
320 SANTA FE DR, SUITE 101, Encinitas, CA 92024(760) 753-3424
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $696.05 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$696.05

Total received

38

Transactions

11

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$172.85
Philips North America LLC$133.45
Boehringer Ingelheim Pharmaceuticals, Inc.$109.98
AstraZeneca Pharmaceuticals LP$76.26
Mallinckrodt Hospital Products Inc.$64.19
Genzyme Corporation$35.44

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 76th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to William Hooper do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Kevin Shaw, MD

Pulmonary Disease

19 yrs NPPES
NPI 1154520864
326 SANTA FE DR STE 100, Encinitas, CA 92024(760) 230-8994
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Stephanie Shin, MD

Pulmonary Disease

15 yrs NPPES
NPI 1023317286
320 SANTA FE DR STE 107-C, Encinitas, CA 92024(760) 230-8994
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Alejandro Pino, MD

Pulmonary Disease

11 yrs NPPES
NPI 1457748089
326 SANTA FE DR STE 100, Encinitas, CA 92024(760) 230-8994
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,926 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,926

Total received

80

Transactions

14

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$670.15
GlaxoSmithKline, LLC.$220.10
Amgen Inc.$194.66
Genzyme Corporation$160.82
Boehringer Ingelheim Pharmaceuticals, Inc.$147.73
Janssen Pharmaceuticals, Inc$114.69

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 86th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Alejandro Pino do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Michelle Zhang, MD

Pulmonary Disease

10 yrs NPPES
NPI 1538521422
354 SANTA FE DR, Encinitas, CA 92024(760) 633-6507
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $623.62 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$623.62

Total received

30

Transactions

9

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$161.76
Regeneron Healthcare Solutions, Inc.$97.57
AstraZeneca Pharmaceuticals LP$88.27
GlaxoSmithKline, LLC.$84.72
Genzyme Corporation$80.86
Electromed, Inc.$37.28

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 75th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Michelle Zhang do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Alisha Kabadi, MD

Pulmonary Disease

8 yrs NPPES
NPI 1356838957
326 SANTA FE DR STE 100, Encinitas, CA 92024(760) 230-8994
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Christina Cheng, MD

Pulmonary Disease

6 yrs NPPES
NPI 1962031112
354 SANTA FE DR, Encinitas, CA 92024(760) 230-2251
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Hannah Robertson, MD

Pulmonary Disease

6 yrs NPPES
NPI 1720601495
354 SANTA FE DR, Encinitas, CA 92024(760) 230-2251
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Pulmonary Disease in Encinitas, CA — Verified | DoctorsProof | DoctorsProof